Inventor · disambiguated record
Ayodele Morris
Also filed as: MORRIS AYODELE
2 granted patents·9 pending applications·1 citations·filing 2014–2017
36Inventor score
Top patents by PatentIndex Score
11 records- 0164US9170264B2Methods of monitoring for adherence to aripiprazole therapyAMERITOX LTD·Filed 2014·Granted Oct 27, 2015·1 cites·35 claims
- 0249US9606132B2Methods of monitoring adherence to lurasidone therapyAMERITOX LTD·Filed 2014·Granted Mar 28, 2017·0 cites·17 claims
- 0349US2016003800A1Methods of monitoring for adherence to aripiprazole therapyAMERITOX LTD·Filed 2015·Application pending·0 cites
- 0444US2017356923A1Methods of monitoring adherence to quetiapine therapyAMERITOX LLC·Filed 2017·Application pending·0 cites
- 0541US2016041192A1Methods of monitoring adherence to quetiapine therapyAMERITOX LTD·Filed 2015·Application pending·0 cites
- 0640US2017299574A1Methods of monitoring for adherence to aripiprazole therapyAMERITOX LLC·Filed 2017·Application pending·0 cites
- 0737US2017192025A1Methods of monitoring adherence to lurasidone therapyAMERITOX LLC·Filed 2017·Application pending·0 cites
- 0831US2016300038A1Methods of normalizing measured drug concentrations in urine using patient specific data and testing for potential non-compliance with a chronic drug treatment regimenAMERITOX LTD·Filed 2016·Application pending·0 cites
- 0930US2016041146A1Methods of normalizing the ratio of measured parent and metabolite drug concentrations in fluids and testing for non-complianceAMERITOX LTD·Filed 2015·Application pending·0 cites
- 1026US2016076075A1Enzymatic hydrolysis of glucuronide conjugated drugs in the presence of water miscible organic mediaAMERITOX LTD·Filed 2015·Application pending·0 cites
- 1125US2018045744A1Normalizing measured drug concentrations in oral fluids and testing for potential non-compliance with drug treatment regimenAMERITOX LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ayodele Morris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →